Market Tracker

03/29 5:16pm ET

Acorda Therapeutics Inc (NASDAQ:ACOR)

26.95
Delayed Data
As of 3:59pm ET
 +0.85 / +3.26%
Today’s Change
16.40
Today|||52-Week Range
33.00
+43.35%
Year-to-Date

Today’s Trading

Previous close26.10
Today’s open25.55
Day’s range25.55 - 29.75
Volume1,259,007
Average volume (3 months)784,194
Market cap$1.2B
Dividend yield--
Data as of 3:59pm ET, 03/29/2017

Growth & Valuation

Earnings growth (last year)-404.00%
Earnings growth (this year)+353.14%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+5.47%
P/E ratioNM
Price/Sales1.64
Price/Book1.79

Competitors

 Today’s
change
Today’s
% change
RGENRepligen Corp+0.35+1.01%
EGRXEagle Pharmaceutical...+1.14+1.39%
EBSEmergent BioSolution...+0.54+1.87%
DERMDermira Inc-0.10-0.28%
Data as of 4:02pm ET, 03/29/2017

Financials

Last reporting dateJanuary 9, 2017
EPS forecast (this quarter)$0.09
Annual revenue (last year)$519.6M
Annual profit (last year)-$34.6M
Net profit margin-6.66%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief Financial &
Accounting Officer
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts